AB
Aaryan Bhalla
About Aaryan Bhalla
Data last updated:
Aaryan Bhalla is a Director at Ervamine Pharma Private Limited (since 2023) and Director at Bhawali Ventures Private Limited (since 2025). The largest current company by reported revenue is Ervamine Pharma Private Limited at ₹8,643 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ervamine Pharma Private Limited U46497DL2023PTC418476 | Director | 11 Aug 2023 | 2023 | ₹8,643 (FY 2025) | Active |
| Bhawali Ventures Private Limited U47912DL2025PTC446790 | Director | 20 Apr 2025 | 2025 | Active |
Board colleagues of Aaryan Bhalla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Kumar Bhalla | 10276602 | Ervamine Pharma Private Limited | Director |
| Rudra Walia | 11065369 | Bhawali Ventures Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aaryan Bhalla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aaryan Bhalla
Aaryan Bhalla currently holds 2 directorships: Ervamine Pharma Private Limited (Director, since 11 Aug 2023, revenue ₹8,643 (FY 2025)); Bhawali Ventures Private Limited (Director, since 20 Apr 2025).
Aaryan Bhalla was first appointed on 11 Aug 2023 as Director at Ervamine Pharma Private Limited. The most recent appointment on record is 20 Apr 2025 at Bhawali Ventures Private Limited.
The current boards of Aaryan Bhalla's companies include Ajay Kumar Bhalla (Ervamine Pharma Private Limited), Rudra Walia (Bhawali Ventures Private Limited).